Filter
201
Filtered Results: 201
Text search:
adenovirus
Featured
Recommendations
24
New Publications
82
Language
Document type
Guidelines
73
No document type
65
Studies & Reports
19
Fact sheets
15
Manuals
12
Strategic & Response Plan
6
Training Material
3
Situation Updates
2
Resource Platforms
2
Infographics
2
Brochures
1
Videos
1
Countries / Regions
Brazil
15
Germany
12
India
9
Paraguay
6
South Africa
6
Latin America and the Carribbean
5
Western and Central Europe
5
West and Central Africa
4
Kenya
3
Guinea
3
Argentina
3
Colombia
2
Global
2
Africa
2
United Kingdom
2
East and Southern Africa
2
Bangladesh
2
Ecuador
2
Myanmar / Burma
2
Ukraine
1
El Salvador
1
Sierra Leone
1
China
1
Rwanda
1
Chile
1
Burkina Faso
1
Peru
1
Philippines
1
Italy
1
USA
1
Venezuela
1
Congo, Democratic Republic of
1
Bolivia
1
Uganda
1
Eastern Europe
1
Russia
1
Ethiopia
1
Honduras
1
Chad
1
South Sudan
1
Indonesia
1
Liberia
1
Authors & Publishers
Publication Years
Category
COVID-19
52
Guidelines
48
Pediatrics
6
Policies
6
Studies & Reports
4
Water
4
Hepatitis
3
Drugs & Medical Equipment
3
Respiratory Infections
3
Disease Prevention & Control
3
Paediatrics
2
Hand Hygiene
2
General Guidelines
2
Virology
2
Infection Control & Prevention (IPC)
2
NCD
2
Clinical Guidelines
2
Information, Education and Communication (IEC)
2
Dental & Eye Care
1
Rabies
1
Pharmacy & Technology
1
Diabetes
1
Dermatology
1
Cancer
1
Cancer Treatment & Resources
1
Yersinia pestis (Plague)
1
Vaccine-preventable Diseases
1
Hemorrhagic Fever
1
Diarrhoeal Disease/Cholera
1
Policies & Guidelines HIV & TB
1
Women & Child Health
1
Community Health
1
Capacity Building
1
Humanitarian Crisis
1
Mental Health
1
Statistics
1
WASH
1
Diarrhoea
1
Communicable Diseases
1
NTDs & Others
1
Dengue
1
Radiology and Diagnostic
1
Toolboxes
Country specific documents
32
Clinical Guidelines
17
Vaxzevria (Astra Zeneca)
17
Immunization Guidelines
11
Infection Control General
7
Hand Hygiene
6
Research
5
Paediatrics
5
Communication Material
5
Research & Pipeline
5
Infection Prevention & Hygiene
4
Access & Strategy
4
Presentation
4
IPC
3
Vaccines & Immunization
3
Influenza Prevention & Control
3
Treatment Guidelines
3
Long COVID/ Post-COVID Syndrome
3
Vector-based Vacines General
3
Johnson & Johnson
3
Booster Doses
3
Surveillance
2
WASH
2
Prevention & Preparedness
2
For Pregnant Women
2
Training, others
2
For Health Worker
2
Clinical Guidelines
2
Logistics & Supply
2
Rational use of Medicine
2
Technical Information
2
Germany
2
Infection Control
2
Preparedness & Prevention
2
Rapid Response
1
Clinical Guidelines
1
Assessment & Studies
1
Meningitis Prevention & Control
1
Laboratory Guidance
1
Ebola Prevention & Control
1
Hand Hygiene
1
Clinical Aspects
1
Country specific
1
Pediatrics
1
Introduction to Global Health
1
Dengue
1
General Mental Health Guidelines
1
Public Health
1
Germany
1
General Studies & Reports
1
Standard Precautions
1
Children
1
Medical professionals
1
Context & Facts
1
COVID-19
1
For Parents & Children
1
Scientific & Research Studies
1
Gender Aspects
1
HIV and COVID-19
1
COVID-19
1
Hospital Readiness/Essential Health Services
1
Vaccination & Strategy
1
Videos
1
Vaccine Candidates & Research
1
COVID-19 Vaccination
1
Preparedness, Response & Risk Communication
1
Dashboards & Resource Platforms
1
TB/COVID-19
1
SARS-CoV-2 Variants
1
COVID-19 Vaccination Information
1
COVAX Initiative
1
Vaccine Hesitancy & Myths
1
Moderna
1
Biontech/Pfizer Comirnaty
1
Sputnik V
1
Inactivated COVID-19 Vaccines
1
Hygiene
1
Hand Hygiene
1
Essential Medicines
1
Essential Medicines & Devices Lists
1
Freshwater use
1
General documents One Health
1
Pharmacovigilance
1
Guidelines & Manuals
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Clinical Guidelines
1
Training Material
1
Co-Morbidities (except TB)
1
National Emergency Response Plans
1
Miscellaneous
1
Diarrhoea
1
Research & Access
1
Technical Information
1
Stewardship
1
Zika Prevention & Control
1
Clinical Guidelines
1
Others
1
Overview & Statistics
1
Laboratory & Diagnostics
1
Situation Reports, others
1
Volunteers
1
Plague Prevention & Control
1
gemäß § 4 Abs. 2 des Gesetzes zur Verhütung und Bekämpfung von
Infektionskrankhei ten beim Menschen (Infektionsschutzgesetz - I fSG)
Ausgabe 2015 (kommentierte Version); gemäß § 4 Abs. 2 des Gesetzes zur Verhütung und Bekämpfung von Infektionskrankheiten beim Menschen (Infektionsschutzgesetz - IfSG
In dieser Version sind die wichtigsten Änderungen zur Vorversion der Falldefinitionen markiert und durch Randnotizen erläuter...
Comment The Lancet Volume 397, ISSUE 10269, P72-74, January 09, 2021
Published:December 08, 2020DOI:https://doi.org/10.1016/S0140-6736(20)32623-4
REG 174 INFORMATION FOR UK HEALTHCARE PROFESSIONALS
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) ir...
An overview of COVID-19 Vaccine AstraZeneca and why it is authorised in the EU. Available in 22 languages
18 Febr. 2021
New England Journal of Medicine
April 9, 2021
DOI: 10.1056/NEJMoa2104840
Learn about the composition and delivery mechanism for the new classes of COVID-19 vaccines based on adenovirus from Johnson & Johnson and AstraZeneca with Dr. Jonathan Genzen, COO of ARUP Laboratories and an Associate Professor at the University of Utah School of Medicine.
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto...
Este documento de referência foi preparado pelo Grupo de Trabalho sobre Vacinas contra COVID-19 do Grupo Consultivo Estratégico de Especialistas em Imunização (SAGE) para orientar as discussões do SAGE em sua reunião extraordinária de 8 de fevereiro de 2021, que resultou na publicação do do...
Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19)
Interim guidance 19 July 2021
CONVIDECIA is based on a modified human adenovirus that expresses the spike S protein of SARS-CoV-2. It is administered as a single dose.
Organización Mundial de la Salud. (2022). Recomendaciones provisionales sobre el uso de la vacuna CanSinoBIO Ad5-nCoV-S [recombinante] (Convidecia™) contra la COVID-19: orientaciones provisionales, primera publicación: 19 de mayo de 2022.
